Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call

Group 1 - Neuronetics, Inc. plans to release its second quarter 2024 financial and operating results on August 12, 2024, prior to market open [1] - The company will host a conference call at 8:30 a.m. Eastern Time on the same day to review its results [1][4] Group 2 - Neuronetics is a leader in neuroscience, focusing on improving mental health through its NeuroStar Advanced Therapy, a non-drug, noninvasive treatment for neurohealth conditions [2] - NeuroStar is FDA-cleared for major depressive disorder (MDD) in adults and adolescents aged 15 and older, as well as for obsessive-compulsive disorder (OCD) and anxiety symptoms in adults with MDD [2] - The treatment has delivered over 6.4 million sessions and is supported by the largest clinical data set for TMS systems for depression, including the world's largest depression Outcomes Registry [2]